Lewis H. Bender - May 2, 2025 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Joseph Talamo, Attorney-in-fact
Stock symbol
INTS
Transactions as of
May 2, 2025
Transactions value $
$0
Form type
4
Date filed
5/6/2025, 04:07 PM
Previous filing
Mar 7, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BENDER LEWIS H President and CEO, Director, 10%+ Owner C/O INTENSITY THERAPEUTICS, INC., 1 ENTERPRISE DRIVE, SUITE 430, SHELTON /s/ Joseph Talamo, Attorney-in-fact 2025-05-06 0001238705

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTS Stock Option (right to buy Common Stock) Award $0 +700K $0.00 700K May 2, 2025 Common Stock 700K $0.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney